Chloe Sakal

2 papers in the library · 178 citations · publishing 2019-2021

Papers

Sort Most recent Most cited

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.

Journal of Psychopharmacology February 18, 2021 Ben Sessa, Laurie Higbed, Steve O’Brien et al. 123 citations

Background: 3,4-methylenedioxymethamphetamine (MDMA) therapy has qualities that make it potentially well suited for patients with addictions, but this has never been explored in a research study. We present data from the Bristol Imperial MDMA in Alcoholism (BIMA) study. This is the first MDMA addiction study, an open-label safety and tolerability proof-of-concept study investigating the...

DOI: 10.1177/0269881121991792 Alcohol use disorder Aud Alcoholism Alcohol addiction +19

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants.

BMJ Case Reports July 15, 2019 Ben Sessa, Chloe Sakal, Steve O’Brien et al. 55 citations

We present the preliminary data in an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder. At this stage, seven participants have completed the full 8-week MDMA-assisted psychotherapy course, including two therapy sessions each with MDMA....

DOI: 10.1136/bcr-2019-230109 Full text Psychedelic therapy Alcohol use disorder MDMA Therapy MDMA-Assisted Psychotherapy +14